A generic biokinetic model for carbon-14

Radiation Protection Dosimetry

Volumn 143, Issue 1, 2011, Pages 42-51

  Manger, R P ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON;

ARTICLE; BIOASSAY; BIOLOGICAL MODEL; BREATH ANALYSIS; CHEMISTRY; FECES; HUMAN; KINETICS; METABOLIC CLEARANCE RATE; METABOLISM; RADIATION DOSE; RADIATION PROTECTION; RADIOMETRY; TISSUE DISTRIBUTION; URINALYSIS; WHOLE BODY COUNTING;

BIOLOGICAL ASSAY; BREATH TESTS; CARBON RADIOISOTOPES; FECES; HUMANS; KINETICS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIATION PROTECTION; RADIOMETRY; TISSUE DISTRIBUTION; URINALYSIS; WHOLE-BODY COUNTING;

EID: 78651434348     PISSN: 01448420     EISSN: 17423406     Source Type: Journal    
DOI: 10.1093/rpd/ncq332     Document Type: Article

References (42)

1. Taylor, D. M. Biokinetic models for the behaviour of carbon-14 from labelled compounds in the human body: can a single generic model be justified? Radiat. Prot. Dosim. 108(3), 187-202 (2004)
2. International Commission on Radiological Protection. Doses to patients from radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18(1-4), pp. 55-58 (1987).
3. Hellman, L., Rosendfeld, R. S., Eidinoff, M. L., Fukushima, D. K., Gallagher, T. F., Wang, C.-I. and Adlersberg, D. Isotopic studies of plasma cholesterol of endogenous and exogenous origin. J. Clin. Invest. 34, 48-60 (1955).
4. International Commission on Radiological Protection. Limits for intakes of radionuclides by workers: part 3. ICRP Publication 30. Ann. ICRP 6(2/3), pp. 4-9 (1981).
5. International Commission on Radiological Protection. Report of the task group on reference man. ICRP Publication 23. Pergamon Press (1975).
6. International Commission on Radiological Protection. Dose coefficients for intakes of radionuclides by workers. ICRP Publication 68. Ann. ICRP 24(4), pp. 1-84 (1994).
7. International Commission on Radiological Protection. Age-dependant doses to members of the public from intake of radionuclides: part 4. ICRP Publication 71. Ann. ICRP 25(3/4), pp. 42-43 (1995).
8. Crawley, F. E. H. and Goddard, E. A. Internal dose from carbon-14 labelled compounds. The metabolism of 14C-labelled potassium cyanide in the rat. Health Phys. 32, 135-142 (1977).
9. Crawley, F. E. H. The metabolism and dosimetry of carbon-14 labelled compounds. In: Proceedings of Fourth International Congress of International Radiation Protection Association, Paris, 2 April, pp. 425-428 (1977).
10. 14 studies in carbohydrate metabolism I. The oxidation of glucose in normal human subjects. J. Biol. Chem. 211, 575-592 (1954).
11. 14 from uniformly labelled glucose into plasma triglycerides in normals and hyperglyceridemics. Metab. Clin. Exp. 11, 893-911 (1962).
12. 2. J. Clin. Invest. 30, 73-76 (1951).
13. 2. Proc. Soc. Exp. Biol. Med. 88, 386-389 (1955).
14. Fukushima, D. K., Dobriner, K. and Gallagher, T. F. Studies with testosterone-d in normal men. J. Biol. Chem. 206, 845-861 (1954).
15. Fukushima, D. K., Bradlowe, H. L., Dobriner, K. and Gallagher, T. F. The fate of testosterone infused intravenously in man. J. Biol. Chem. 206, 863-874 (1954).
16. 14-estradiol in women. J. Clin. Invest. 36, 1266-1278 (1957).
17. Migeon, C. L., Sandberg, A. A., Paul, A. C. and Samuels, L. C. Metabolism of 4-14C-corticosterone in man. J. Clin. Endocrinol. Metab. 16, 1291-1298 (1956).
18. 14 in man. J. Clin. Invest. 33, 1106-1115 (1954).
19. 11C]thymidine. Br. J. Radiol. 67, 292-295 (1994).
20. International Commission on Radiological Protection. Radiation doses to patients from radiopharmaceuticals. Addendum to ICRP 53. Publication 80. Ann. ICRP 28(3) (1998).
21. Stather, J. W., Smith, H., Bailey, M. R., Birchall, A., Bulman, R. A. and Crawley, F. E. H. The retention of 14C-DTPA in human volunteers after inhalation or intravenous injection. Health Phys. 44, 45-42 (1981).
22. Crawley, F. E. H. and Haines, J. W. Further studies on the metabolism and dosimetry of carbon-14 labelled compounds. National Radiological Protection Board: Annual Research and Development Report 1977. NRPB R&D2, April, Her Majesty's Stationery Office (1978).
23. Eriksson, B., Ottersgard Brorsson, A.-K., Hallström, G., Sjödin, T. and Gunarsson, P. O. Pharmacokinetics of 14C-delmopinol in the healthy male volunteer. Xenobiotica 28, 1075-1081 (1998).
24. Webber, C. et al. Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects. Xenobiotica 33, 625-641 (2003).
25. Leide-Svegborn, S. et al. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur. J. Nucl. Med. 26(6), 573-580 (1999).
26. Gunnarsson, M et al. AMS studies of the long-term turnover of 14C-labelled fat in man. Nucl. Instrum. Methods Phys. Res. B 172, 939-943 (2000).
27. Gunnarsson, M. Biokinetics and radiation dosimetry of 14C-labelled triolein, urea, glycocholic acid and xylose in man: studies related to nuclear medicine "breath tests" using accelerator mass spectrometry. Doctoral dissertation. Department of Radiation Physics, Lund University, ISBN 91-628-5316-3 (2002).
28. Gunnarsson, M., Leide-Svegborn, S., Stenström, K., Skog, G., Nilsson, L.-E., Hellborg, R. and Mattsson, S. No radiation protection reasons for restrictions on urea breath tests in children. Br. J. Radiol. 75, 982-986 (2002).
29. Gunnarsson, M., Stenström, K., Leide-Svegborn, S., Faarinen, M., Magnusson, C. E., Å berg, M., Skog, G., Hellborg, R. and Mattsson, S. Biokinetics and radiation dosimetry for patients undergoing a glycerol tri[1-14C]oleate fat malabsorption breath test. Appl. Radiat. Isot. 58, 517-526 (2003).
30. Gunnarsson, M., Leide-Svegborn, S., Stenström, K., Skog, G., Nilsson, L.-E., Hellborg, R. and Mattsson, S. Long-term biokinetics and radiation exposure of patients undergoing 14C-glycocholic acid and 14C-xylose breath tests for diagnosis of small intestinal bacterial overgrowth. Cancer Biother. Radiopharm. 22(6), 762-771 (2007).
31. Whillans, D. W. Structure of physiologically based biokinetic model for use in 14C and organically bound tritium dosimetry. Radiat. Prot. Dosim. 105, 189-192 (2003).
32. Richardson, R. B. and Dunford, D. W. A biochemicalbased model for the dosimetry of dietary organically bound tritium-part 1: physiological criteria. Health Phys. 85(5), 523-538 (2003).
33. Richardson, R. B. and Dunford, D. W. A biochemicalbased model for the dosimetry of dietary organically bound tritium-part 2: dosimetric evaluation. Health Phys. 85(5), 539-552 (2003).
34. Brown, R. M. and Chant, L. A. The dietary intake, excretion and dosimetry of carbon-14. Atomic Energy Control Board, INFO-0510 (1995).
35. 14C in mammals: a proposed generic model. Radiat. Environ. Biophys. 48, 29-45 (2009).
36. International Commission on Radiological Protection. Limits for intakes by workers: part 1. ICRP Publication Ann. ICRP 2(3/4) (1979).
37. Leggett, R. W. A biokinetic model for carbon dioxide and bicarbonate. Radiat. Prot. Dosim. 108(3), 203-213 (2004).
38. Leggett, R. W. Private communication to R. M. Manger (2010).
39. International Commission on Radiological Protection. Human respirator tract model for radiological protection. ICRP Publication 66. Ann. ICRP 24(1-3) (1994).
40. Wolfram Research, Inc. Mathematica, Version 7.0 (2008).
41. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21(1-3) (1991).
42. Eckerman, K. F., Leggett, R. W. and Cristy, M. et al. Dose and Risk Calculation Software, Version 9.0. ORNL/TM-2001/190.